These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 7534009)
41. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer. Kreipe H; Feist H; Fischer L; Felgner J; Heidorn K; Mettler L; Parwaresch R Cancer Res; 1993 Apr; 53(8):1956-61. PubMed ID: 8096798 [TBL] [Abstract][Full Text] [Related]
42. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications. Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096 [TBL] [Abstract][Full Text] [Related]
43. Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples. Mueller RE; Parkes RK; Andrulis I; O'Malley FP Genes Chromosomes Cancer; 2004 Apr; 39(4):288-97. PubMed ID: 14978790 [TBL] [Abstract][Full Text] [Related]
44. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer. Rudolph P; Alm P; Olsson H; Heidebrecht HJ; Fernö M; Baldetorp B; Parwaresch R Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641 [TBL] [Abstract][Full Text] [Related]
45. [Proliferative activity and defective replication in breast cancer]. Kreipe H; Zeidler R; Kneitz H; Feist H Verh Dtsch Ges Pathol; 1994; 78():36-7. PubMed ID: 7534009 [TBL] [Abstract][Full Text] [Related]
46. Clinical relevance of breast cancer biology. Oza AM; Tannock IF Hematol Oncol Clin North Am; 1994 Feb; 8(1):1-14. PubMed ID: 7512087 [TBL] [Abstract][Full Text] [Related]